Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Partner Alnylam Presents Data on Programs Using Tekmira’s SNALP Technology at Keystone Meeting Feb 12, 2009 ... Read more Summary ToggleTekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP Jan 23, 2009 Tekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP 15.9 KB ... Read more Summary ToggleTekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam Jan 08, 2009 Tekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam 17.3 KB ... Read more Summary ToggleTekmira Partner Alnylam Files First IND for an RNAi Therapeutic Utilizing SNALP Dec 23, 2008 Tekmira Partner Alnylam Files First IND for an RNAi Therapeutic Utilizing SNALP 16.7 KB ... Read more Summary ToggleTekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update Nov 13, 2008 Tekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update 28.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Nov 10, 2008 Tekmira Pharmaceuticals Conference Call Advisory 12.2 KB 2008 Third Quarter Operating Results ... Read more Summary ToggleTekmira Pharmaceuticals Announces Presentation of Data Using SNALP RNAi Delivery Technology Oct 22, 2008 Tekmira Pharmaceuticals Announces Presentation of Data Using SNALP RNAi Delivery Technology 16.7 KB ... Read more Summary ToggleTekmira Pharmaceuticals Expands Executive Management Team Sep 29, 2008 Tekmira Pharmaceuticals Expands Executive Management Team 17.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Collaborator National Cancer Institute Presents Anti-Tumor Data at Liver Cancer Conference Sep 08, 2008 Tekmira Pharmaceuticals Collaborator National Cancer Institute Presents Anti-Tumor Data at Liver Cancer Conference 17.7 KB Tekmira Also Presents at Charles River Biotech Symposium ... Read more Summary ToggleTekmira Pharmaceuticals Publishes Research that Addresses Critical Issue in the RNAi Field Aug 26, 2008 Tekmira Pharmaceuticals Publishes Research that Addresses Critical Issue in the RNAi Field 16.7 KB ... Read more Pagination First page First Previous page Previous … Page 49 Current page 50 Page 51 Page 52 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Partner Alnylam Presents Data on Programs Using Tekmira’s SNALP Technology at Keystone Meeting Feb 12, 2009 ... Read more Summary ToggleTekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP Jan 23, 2009 Tekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP 15.9 KB ... Read more Summary ToggleTekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam Jan 08, 2009 Tekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam 17.3 KB ... Read more Summary ToggleTekmira Partner Alnylam Files First IND for an RNAi Therapeutic Utilizing SNALP Dec 23, 2008 Tekmira Partner Alnylam Files First IND for an RNAi Therapeutic Utilizing SNALP 16.7 KB ... Read more Summary ToggleTekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update Nov 13, 2008 Tekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update 28.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Nov 10, 2008 Tekmira Pharmaceuticals Conference Call Advisory 12.2 KB 2008 Third Quarter Operating Results ... Read more Summary ToggleTekmira Pharmaceuticals Announces Presentation of Data Using SNALP RNAi Delivery Technology Oct 22, 2008 Tekmira Pharmaceuticals Announces Presentation of Data Using SNALP RNAi Delivery Technology 16.7 KB ... Read more Summary ToggleTekmira Pharmaceuticals Expands Executive Management Team Sep 29, 2008 Tekmira Pharmaceuticals Expands Executive Management Team 17.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Collaborator National Cancer Institute Presents Anti-Tumor Data at Liver Cancer Conference Sep 08, 2008 Tekmira Pharmaceuticals Collaborator National Cancer Institute Presents Anti-Tumor Data at Liver Cancer Conference 17.7 KB Tekmira Also Presents at Charles River Biotech Symposium ... Read more Summary ToggleTekmira Pharmaceuticals Publishes Research that Addresses Critical Issue in the RNAi Field Aug 26, 2008 Tekmira Pharmaceuticals Publishes Research that Addresses Critical Issue in the RNAi Field 16.7 KB ... Read more Pagination First page First Previous page Previous … Page 49 Current page 50 Page 51 Page 52 … Next page Next Last page Last
Tekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP 15.9 KB
Tekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam 17.3 KB
Tekmira Pharmaceuticals Corporation Announces Third Quarter 2008 Operating Results and Provides Program Update 28.1 KB
Tekmira Pharmaceuticals Collaborator National Cancer Institute Presents Anti-Tumor Data at Liver Cancer Conference 17.7 KB
